3rd Circ. Revives FTC Claim Against Supplement Maker

Law360, New York (October 26, 2010, 7:12 PM EDT) -- A federal appeals court has revived the Federal Trade Commission's motion to hold dietary supplement maker Lane Labs-USA Inc. in contempt for violating a consent judgment by deceptively advertising a calcium supplement and a fertility treatment.

The U.S. Court of Appeals for the Third Circuit ruled Tuesday that a lower court had “committed clear error” in denying the FTC's motion and remanded the case.

The FTC is seeking to hold Lane Labs and its president in contempt of a consent decree filed in 2000 in the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.